EURUSD Bid: --
USDJPY Bid: --
GBPUSD Bid: --
USDCHF Bid: --
AUDUSD Bid: --
USDCAD Bid: --
NZDUSD Bid: --
EURGBP Bid: --
GBPJPY Bid: --
WTI Bid: --
BRENT Bid: --
XAUUSD Bid: --
XAGUSD Bid: --
SPX500 Bid: --
DAX40 Bid: --
US30 Bid: --
JPN225 Bid: --
NAS100 Bid: --
UK100 Bid: --
BTCUSD Bid: --
ETHUSD Bid: --
LTCUSD Bid: --
XRPUSD Bid: --
EURUSD Bid: --
USDJPY Bid: --
GBPUSD Bid: --
USDCHF Bid: --
AUDUSD Bid: --
USDCAD Bid: --
NZDUSD Bid: --
EURGBP Bid: --
GBPJPY Bid: --
WTI Bid: --
BRENT Bid: --
XAUUSD Bid: --
XAGUSD Bid: --
SPX500 Bid: --
DAX40 Bid: --
US30 Bid: --
JPN225 Bid: --
NAS100 Bid: --
UK100 Bid: --
BTCUSD Bid: --
ETHUSD Bid: --
LTCUSD Bid: --
XRPUSD Bid: --

July FX Volumes Beat 2025 Levels Across CLS, Cboe and CME

Posted: 13th Aug 2026

FX activity remained substantially above year-earlier levels across several parts of the institutional currency market in July. CLS reported a 14.7% year-on-year increase in average daily traded volume, after Cboe and CME also recorded higher FX activity for the month.

CLS reported average daily traded volume of $2.658 trillion in July 2026, up from $ 2.317 trillion in July 2025. Cboe Global FX average daily volume rose 25.9% year-on-year to $61.071 billion, while CME’s FX average daily volume increased 9% to 811,000 contracts.

CLS Volumes Rise Despite Pullback from June

CLS's report shows that all three of its FX product categories increased from July 2025 onward.

FX forwards average daily volume rose 18% year-on-year to $236 billion, the fastest percentage increase among the three categories. FX swaps, still by far the largest component of CLS activity, rose 14.9% to $1.817 trillion. FX spot increased 12.7% to $605 billion.

The monthly comparison looks less optimistic. CLS’s total average daily traded volume fell 5.9%. All categories except FX spot decreased month-on-month.

Thus, July cooled from the previous month but remained significantly higher than the same month last year.

Cboe Shows a Similar Pattern

The Cboe Global FX business moved in the same direction. Its July ADV of $61.071 billion was nearly 26% higher than $48.514 billion in July 2025, and down approximately 5% from $64.267 billion in June 2026.

Cboe Global FX represents activity on an institutional FX trading venue, whereas CLS’s figures cover FX instructions submitted across spot, forwards and swaps within its settlement ecosystem.

Finance Magnates previously covered Cboe’s July report through a different angle, focusing on record Mini-SPX options activity and same-day trading’s share of SPX options volume.

For FX, the same monthly report showed strong year-on-year growth alongside a June-to-July pullback.

CME Shows Growth in Listed FX and EBS Spot

CME’s FX data are another dimension to the picture. Unlike CLS, which reports settlement-related instructions, and Cboe Global FX, which reflects activity on an institutional spot FX venue, CME’s headline FX figure is measured in listed futures and options contracts, which ADV increased 9% year-on-year to 811,000 contracts in July.

CME also reported a separate spot-market signal through EBS, where average daily notional value rose 25% to $70 billion. The product-level data point is in the same direction.

Japanese Yen futures ADV increased 39% to 184,000 contracts, while FX Link ADV rose 38% to 55,000 contracts, representing $5.2 billion in notional per leg.

July’s year-over-year increase was evident across several parts of the FX market infrastructure, from CLS settlement-related flows and institutional spot venues to listed derivatives.

The month-on-month pullback at CLS and Cboe keeps the conclusion narrower: July was stronger than 2025 across the reported datasets, but it is not a continuation of June’s higher levels.

This article was written by Tanya Chepkova at www.financemagnates.com.

Source: Finance Magnates

Follow us on
Website Managed by BuiltByGo
Disclaimer: The information provided on FX Axe is for educational and informational purposes only and should not be construed as financial advice. Trading Foreign Exchange (FX), Contracts for Difference (CFDs), and other leveraged financial products involves a high level of risk and may not be suitable for all investors. Leverage can work both to your advantage and disadvantage, and as a result, you may lose more than your initial investment. Before deciding to trade FX, CFDs, or any other financial instrument, you should carefully consider your investment objectives, level of experience, and risk tolerance. You should not invest money that you cannot afford to lose. It is strongly advised that you seek independent financial advice if you have any doubts. FX Axe does not provide investment, tax, legal, or financial advice of any kind. We may receive compensation from brokers and partners featured on this website, but such relationships do not influence our reviews or recommendations. All reviews are based on our own opinions and research and should not be interpreted as endorsements or guarantees of any service. Past performance is not indicative of future results. The trading of FX and CFDs carries a significant risk of loss. By using this website, you acknowledge that FX Axe bears no responsibility for any losses you may incur from your trading activities or reliance on information provided here.

Affiliate Disclosure: Some of the links and references on FX Axe may relate to third-party brokers or service providers. In certain cases, we may receive compensation if you choose to engage with these providers through our website. This helps support the ongoing operation of the site and allows us to continue publishing content at no direct cost to our readers. Our content is created with the aim of being informative and useful. While commercial relationships may exist, we strive to ensure that the information presented remains objective and based on our own research and perspective.
cross